Wegovy, the weight-loss medication, gets FDA approval for use as heart disease prevention drug
Wegovy has been FDA-approved for heart disease prevention. The semaglutide, originally approved for weight loss, is now approved to reduce the risk of cardiovascular death, heart attack and stroke.
Doctors say AI is a 'game-changer' for number 1 killer of Americans
The Mayo Clinic in Rochester, Minnesota, is using AI to screen for heart problems, in hopes of saving lives in light of recent shortages of cardiologists.
Novo Nordisk weight loss drug Wegovy cuts heart disease risk by 20%, trial shows
Novo Nordisk said the results of a late-stage drug trial showed weight loss drug Wegovy also can cut the risk of heart disease in certain patients.
Juuling: the latest smoking trend to hit college campuses
What is Julling and how safe is it for teens?